Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Symbravo ingredients mechanism of action?Are there income restrictions for lipitor's patient program?How does iron rich food intake impact lipitor's efficacy?Pramlintide acetate price?
See the DrugPatentWatch profile for Acalabrutinib
Calquence (acalabrutinib) was first approved by the FDA on November 14, 2017, for adults with mantle cell lymphoma who have received at least one prior therapy. If you’d like, I can list later FDA approvals/indications with their dates.
Other Questions About Acalabrutinib :